Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/FCF ratio high or low?
The EV/FCF ratio of 15.06x is 14% above its estimated 5-year average of 13.22x, near the low end of its estimated 5-year range (4.24x–66.53x).
As of 2026-10-06T21:58:48.879Z. 60.58% below its estimated 12-month average of 38.21x.
Calculation as of: 2026-10-06T21:58:48.879Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: bd1da7b8fdbe91cdca625bc0f024fb4dc004e27004d76598aac54aa781ae1c7d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
15.06x
EV/FCF RATIO AVG TTM
38.21x
EV/FCF RATIO AVG 3Y
38.21x
EV/FCF RATIO AVG 5Y
13.22x
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-60.58%
CURRENT VS 3Y AVG
-60.58%
CURRENT VS 5Y AVG
+13.91%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
24.85x
median of 205 covered companies
CURRENT VS SECTOR MEDIAN
-39.40%
vs the sector median at left
Zevra Therapeutics, Inc.
Market Cap
$634.30M
EV/FCF Ratio
15.06x
TTM Avg
38.21x
3Y Avg
38.21x
5Y Avg
13.22x
Market Cap
$656.59M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zevra Therapeutics, Inc. (ZVRA) | $634.30M | 15.06x | 38.21x | 38.21x | 13.22x |
| Prime Medicine, Inc. (PRME)vs › | $632.16M | N/A | N/A | N/A | N/A |
| OmniAb, Inc. (OABI)vs › | $630.63M | N/A | 710.97x | 756.83x | 756.83x |
| Aura Biosciences, Inc. (AURA)vs › | $638.20M | N/A | N/A | N/A | N/A |
| SOPHiA GENETICS S.A. (SOPH)vs › | $619.15M | N/A | N/A | N/A | N/A |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $656.59M | N/A | N/A | N/A | N/A |
| Climb Bio, Inc. (CLYM)vs › | $611.57M | N/A | 370.81x | 370.81x | 370.81x |
| Starling Oncology, Inc. (STLN)vs › | $657.89M | N/A | N/A | N/A | N/A |
| Annexon, Inc. (ANNX)vs › | $660.29M | N/A | N/A | N/A | N/A |
| Helus Pharma Inc. (HELP)vs › | $666.95M | N/A | N/A | N/A | N/A |
EV/FCF
15.1x
P/FCF
19.5x
FCF Yield
5.13%
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2026-10-05 | 15.74x |
| 2026-10-02 | 14.40x |
| 2026-10-01 | 14.76x |
| 2026-09-30 | 16.25x |
| 2026-09-29 | 16.94x |
| 2026-09-28 | 16.87x |
| 2026-09-25 | 16.38x |
| 2026-09-24 | 16.79x |
| 2026-09-23 | 16.91x |
| 2026-09-22 | 17.40x |
| 2026-09-21 | 17.57x |
| 2026-09-18 | 17.45x |
| 2026-09-17 | 17.89x |
| 2026-09-16 | 17.81x |
| 2026-09-15 | 17.53x |
| 2026-09-14 | 18.28x |
| 2026-09-11 | 18.21x |
| 2026-09-10 | 18.30x |
| 2026-09-09 | 18.26x |
| 2026-09-08 | 19.47x |
| 2026-09-04 | 18.94x |
| 2026-09-03 | 19.20x |
| 2026-09-02 | 18.75x |
| 2026-09-01 | 18.30x |
| 2026-08-31 | 17.70x |
| 2026-08-28 | 17.38x |
| 2026-08-27 | 17.90x |
| 2026-08-26 | 17.70x |
| 2026-08-25 | 18.26x |
| 2026-08-24 | 17.53x |
| 2026-08-21 | 17.94x |
| 2026-08-20 | 17.98x |
| 2026-08-19 | 18.43x |
| 2026-08-18 | 17.38x |
| 2026-08-17 | 17.30x |
| 2026-08-14 | 16.91x |
| 2026-08-13 | 16.64x |
| 2026-08-12 | 17.13x |
| 2026-08-11 | 16.94x |
| 2026-08-10 | 17.21x |
| 2026-08-07 | 17.36x |
| 2026-08-06 | 17.96x |
| 2026-08-05 | 45.23x |
| 2026-08-04 | 45.18x |
| 2026-08-03 | 42.86x |
| 2026-07-31 | 40.09x |
| 2026-07-30 | 40.74x |
| 2026-07-29 | 41.45x |
| 2026-07-28 | 41.20x |
| 2026-07-27 | 41.10x |
| 2026-07-24 | 40.19x |
| 2026-07-23 | 55.28x |
| 2026-07-22 | 53.36x |
| 2026-07-21 | 54.93x |
| 2026-07-20 | 52.81x |
| 2026-07-17 | 56.54x |
| 2026-07-16 | 56.49x |
| 2026-07-15 | 57.50x |
| 2026-07-14 | 58.00x |
| 2026-07-13 | 58.61x |
| 2026-07-10 | 59.47x |
| 2026-07-09 | 62.45x |
| 2026-07-08 | 66.53x |
| 2026-07-07 | 64.97x |
| 2026-07-06 | 62.60x |
| 2026-07-02 | 62.65x |
| 2026-07-01 | 61.79x |
| 2026-06-30 | 64.46x |
| 2026-06-29 | 62.80x |
| 2026-06-26 | 60.33x |
| 2026-06-25 | 58.86x |
| 2026-06-24 | 58.10x |
| 2026-06-23 | 57.70x |
| 2026-06-22 | 55.93x |
| 2026-06-18 | 57.20x |
| 2026-06-17 | 55.73x |
| 2026-06-16 | 55.93x |
| 2026-06-15 | 55.43x |
| 2026-06-12 | 55.93x |
| 2026-06-11 | 57.55x |
| 2026-06-10 | 60.22x |
| 2026-06-09 | 61.03x |
| 2026-06-08 | 53.11x |
| 2026-06-05 | 45.64x |
| 2026-06-04 | 48.46x |
| 2026-06-03 | 47.40x |
| 2026-06-02 | 47.00x |
| 2026-06-01 | 50.08x |
| 2026-05-29 | 50.58x |
| 2026-05-28 | 49.63x |
| 2026-05-27 | 47.35x |
| 2026-05-26 | 44.17x |
| 2026-05-22 | 42.71x |
| 2026-05-21 | 45.03x |
| 2026-05-20 | 43.77x |
| 2026-05-19 | 43.57x |
| 2026-05-18 | 44.73x |
| 2026-05-15 | 47.66x |
| 2026-05-14 | 50.94x |
| 2026-05-13 | 48.21x |
| 2026-05-12 | 47.86x |
| 2026-05-11 | 46.60x |
| 2026-05-08 | 48.26x |
| 2026-05-07 | 47.61x |
| 2022-06-30 | 5.86x |
| 2022-06-29 | 6.59x |
| 2022-06-28 | 6.08x |
| 2022-06-27 | 6.66x |
| 2022-06-24 | 6.55x |
| 2022-06-23 | 6.48x |
| 2022-06-22 | 5.86x |
| 2022-06-21 | 5.60x |
| 2022-06-17 | 5.23x |
| 2022-06-16 | 5.01x |
| 2022-06-15 | 4.98x |
| 2022-06-14 | 4.68x |
| 2022-06-13 | 5.34x |
| 2022-06-10 | 5.64x |
| 2022-06-09 | 7.28x |
| 2022-06-08 | 7.43x |
| 2022-06-07 | 7.98x |
| 2022-06-06 | 6.81x |
| 2022-06-03 | 6.81x |
| 2022-06-02 | 6.84x |
| 2022-06-01 | 6.26x |
| 2022-05-31 | 6.48x |
| 2022-05-27 | 6.70x |
| 2022-05-26 | 6.37x |
| 2022-05-25 | 5.71x |
| 2022-05-24 | 6.08x |
| 2022-05-23 | 6.70x |
| 2022-05-20 | 7.76x |
| 2022-05-19 | 8.24x |
| 2022-05-18 | 6.95x |
| 2022-05-17 | 6.59x |
| 2022-05-16 | 5.60x |
| 2022-05-13 | 4.54x |
| 2022-05-12 | 5.05x |
| 2022-05-11 | 4.24x |
| 2022-05-10 | 5.45x |
| 2022-05-09 | 4.68x |
| 2022-05-06 | 5.12x |
| 2022-05-05 | 5.64x |
| 2022-05-04 | 6.15x |
| 2022-05-03 | 5.67x |
| 2022-05-02 | 6.33x |
| 2022-04-29 | 5.89x |
| 2022-04-28 | 5.38x |
| 2022-04-27 | 5.64x |
| 2022-04-26 | 5.80x |
| 2022-04-25 | 6.55x |
| 2022-04-22 | 6.84x |
| 2022-04-21 | 5.01x |
| 2022-04-20 | 5.86x |
| 2022-04-19 | 6.04x |
| 2022-04-18 | 4.72x |
| 2022-04-14 | 5.16x |
| 2022-04-13 | 6.29x |
| 2022-04-12 | 5.56x |
| 2022-04-11 | 5.89x |
| 2022-04-08 | 6.99x |
| 2022-04-07 | 8.09x |
| 2022-04-06 | 8.05x |
| 2022-04-05 | 8.57x |
| 2022-04-04 | 8.60x |
| 2022-04-01 | 8.46x |
| 2022-03-31 | 6.49x |
| 2022-03-30 | 7.48x |
| 2022-03-29 | 7.34x |
| 2022-03-28 | 6.73x |
| 2022-03-25 | 6.73x |
| 2022-03-24 | 7.69x |
| 2022-03-23 | 6.52x |
| 2022-03-22 | 7.04x |
| 2022-03-21 | 6.59x |
| 2022-03-18 | 7.58x |
| 2022-03-17 | 8.58x |
| 2022-03-16 | 7.38x |
| 2022-03-15 | 6.80x |
| 2022-03-14 | 6.39x |
| 2022-03-11 | 7.17x |
| 2022-03-10 | 7.82x |
| 2022-03-09 | 8.40x |
| 2022-03-08 | 7.62x |
| 2022-03-07 | 7.96x |
| 2022-03-04 | 7.28x |
| 2022-03-03 | 7.93x |
| 2022-03-02 | 9.12x |
| 2022-03-01 | 8.75x |
| 2022-02-28 | 9.57x |
| 2022-02-25 | 9.33x |
| 2022-02-24 | 9.40x |
| 2022-02-23 | 8.23x |
| 2022-02-22 | 8.85x |
| 2022-02-18 | 8.75x |
| 2022-02-17 | 8.58x |
| 2022-02-16 | 9.81x |
| 2022-02-15 | 10.39x |
| 2022-02-14 | 10.11x |
| 2022-02-11 | 10.18x |
| 2022-02-10 | 11.69x |
| 2022-02-09 | 12.00x |
| 2022-02-08 | 11.69x |
| 2022-02-07 | 11.89x |
| 2022-02-04 | 11.69x |
| 2022-02-03 | 11.55x |
| 2022-02-02 | 11.96x |
| 2022-02-01 | 13.81x |
| 2022-01-31 | 13.94x |
| 2022-01-28 | 11.31x |
| 2022-01-27 | 10.39x |
| 2022-01-26 | 11.24x |
| 2022-01-25 | 12.20x |
| 2022-01-24 | 12.03x |
| 2022-01-21 | 11.45x |
| 2022-01-20 | 13.33x |
| 2022-01-19 | 15.55x |
| 2022-01-18 | 16.65x |
| 2022-01-14 | 17.30x |
| 2022-01-13 | 17.16x |
| 2022-01-12 | 18.46x |
| 2022-01-11 | 19.48x |
| 2022-01-10 | 18.73x |
| 2022-01-07 | 18.80x |
| 2022-01-06 | 18.01x |
| 2022-01-05 | 17.84x |
| 2022-01-04 | 19.25x |
| 2022-01-03 | 20.96x |
| 2021-12-31 | 17.49x |
| 2021-12-30 | 18.40x |
| 2021-12-29 | 18.78x |
| 2021-12-28 | 17.04x |
| 2021-12-27 | 19.58x |
| 2021-12-23 | 18.40x |
| 2021-12-22 | 17.84x |
| 2021-12-21 | 18.15x |
| 2021-12-20 | 16.10x |
| 2021-12-17 | 14.25x |
| 2021-12-16 | 13.63x |
| 2021-12-15 | 14.53x |
| 2021-12-14 | 13.84x |
| 2021-12-13 | 14.22x |
| 2021-12-10 | 16.55x |
| 2021-12-09 | 17.39x |
| 2021-12-08 | 17.70x |
| 2021-12-07 | 16.62x |
| 2021-12-06 | 15.47x |
| 2021-12-03 | 14.04x |
| 2021-12-02 | 15.79x |
| 2021-12-01 | 15.12x |
| 2021-11-30 | 14.43x |
| 2021-11-29 | 14.53x |
| 2021-11-26 | 15.19x |
| 2021-11-24 | 15.99x |
| 2021-11-23 | 15.89x |
| 2021-11-22 | 15.47x |
| 2021-11-19 | 16.41x |
| 2021-11-18 | 16.03x |
| 2021-11-17 | 16.24x |
| 2021-11-16 | 18.29x |
Showing the most recent 260 of 356 data points. The chart above shows the full history.
